Natus Medical, Inc. (BABY) Misses Q2 EPS by 1c; Lowers FY11 Outlook
Tweet
Share
E-mailGet Alerts BABY Hot Sheet
Join SI Premium – FREE
Natus Medical, Inc. (NASDAQ: BABY) reported Q2 EPS of $0.13, $0.01 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $58.1 million versus the consensus estimate of $57.93 million.
Natus Medical, Inc. sees FY2011 EPS of $0.58-$0.60, versus prior guidance of $0.80-$0.81 and the consensus of $0.74. Natus Medical, Inc. sees FY2011 revenue of $236 million, versus prior guidance of $250 million and the consensus of $243.36 million.
Natus Medical, Inc. sees FY2011 EPS of $0.58-$0.60, versus prior guidance of $0.80-$0.81 and the consensus of $0.74. Natus Medical, Inc. sees FY2011 revenue of $236 million, versus prior guidance of $250 million and the consensus of $243.36 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
